Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
- PMID: 29025980
- DOI: 10.2967/jnumed.117.197988
Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
Comment in
-
Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.J Nucl Med. 2018 Apr;59(4):714-715. doi: 10.2967/jnumed.117.205351. Epub 2017 Dec 21. J Nucl Med. 2018. PMID: 29269571 No abstract available.
-
Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.J Nucl Med. 2018 Apr;59(4):715-716. doi: 10.2967/jnumed.117.206946. Epub 2018 Feb 1. J Nucl Med. 2018. PMID: 29419476 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources